Outcomes and risk factors for delayed-onset postoperative respiratory failure: a multi-center case-control study by

Jacqueline C Stocking1, Christiana Drake2, J Matthew Aldrich3

  • 1Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of California Davis, 4150 V Street, Suite 3400, Sacramento, CA, 95817, USA. jcstocking@ucdavis.edu.

BMC Anesthesiology
|May 15, 2022
PubMed

Insights

Late postoperative respiratory failure (L-PRF) in adults is linked to worse outcomes. Pre-existing neurologic disease, longer anesthesia, and high peak inspiratory pressures are key risk factors for L-PRF.

Area of Science:

  • Medical research
  • Surgical outcomes
  • Respiratory medicine

Background:

  • Postoperative respiratory failure (PRF) following elective surgery is a significant concern.
  • Early PRF (E-PRF) and late PRF (L-PRF) may have distinct causes and consequences.
  • Understanding L-PRF is crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate the risk factors and outcomes associated with late PRF (L-PRF).
  • To compare L-PRF with early PRF (E-PRF) and patients without PRF (No-PRF).

Main Methods:

  • Retrospective matched case-control study of 59,073 adult patients undergoing elective surgery.
  • Patients with L-PRF were matched 1:1 with No-PRF controls.
  • Risk factors and outcomes were analyzed comparing L-PRF, E-PRF, and No-PRF groups.

Main Results:

  • L-PRF was associated with higher morbidity, mortality, longer hospital/ICU stays, and increased costs compared to No-PRF.
  • Risk factors for L-PRF included pre-existing neurologic disease (OR 4.36), anesthesia duration per hour (OR 1.22), and peak inspiratory pressure (OR 1.14).
  • These factors were identified compared to No-PRF patients.

Conclusions:

  • Pre-existing neurologic disease, prolonged anesthesia, and high intraoperative peak inspiratory pressures are associated with L-PRF.
  • Interventions targeting these identified risk factors warrant further investigation.
  • L-PRF represents a distinct clinical entity with significant adverse outcomes.
Abstract

Related Concept Videos

Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...